Industry News

More Usable, More Affordable: Baseus Launches Nomos NU1 12-in-1 Air Spacemate 12-in-1 Docking Station

SHENZHEN, China, June 3, 2025 /PRNewswire/ -- Baseus has become a leading name in the consumer electronics industry over the past decade and continues to make waves across the world. Through dedication and hard work, the company has mastered creating innovative, intuitive, and exciting new produc...

2025-06-03 12:54 2085

Tianjin boosts workforce development

BEIJING, June 3, 2025 /PRNewswire/ -- A report from China Daily Tianjin launched its 2025 Skills Week on May 13 in the city's Hedong district, placing a strong focus on vocational training and employment. Tianjin Public Vocational...

2025-06-03 12:03 2059

Translators' Voices: China shares technological achievements with the world for mutual benefit

BEIJING, June 2, 2025 /PRNewswire/ -- May 30, 2025 marks the ninth National Science and Technology Workers Day. In the early morning of the previous day, Tianwen-2, the country's first asteroid probe and sampling mission, soared into the sky, carrying with it humanity's aspirations for the stars ...

2025-06-03 09:35 1522

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer

SAN FRANCISCO and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2025-06-03 09:00 3778

2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors

SAN FRANCISCO and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...

2025-06-03 09:00 5573

Jenscare released 30-day follow-up results of LuX-Valve Plus TRINITY study and 1-year follow-up results of JensClip TMVr at EuroPCR 2025

BEIJING, June 2, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 30-day follow-up results of TRINITY Trial of LuX-Valve Plus, a promising self-developed TTVR system, and 1-year outcomes of JensC...

2025-06-03 09:00 1770

XellSmart Secures FDA Clearance for Three Phase I INDs of Allogeneic iPSC-Derived Cell Therapies Targeting Major CNS Diseases: Parkinson's Diseases, Spinal Cord Injury and ALS

SUZHOU, China, June 2, 2025 /PRNewswire/ -- XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell therapies. To date, the company has received seven Investigational New Drug (IND) approvals for regis...

2025-06-03 09:00 1759

FiEE, Inc. Closes Its First Day of Trading on NASDAQ

Company resumed trading under its existing symbol "MINM"  HONG KONG, June 2, 2025 /PRNewswire/ -- FiEE, Inc. (NASDAQ:MINM) ("FiEE, Inc." or the "Company"), a technology company integrating IoT, connectivity and AI to redefine brand management solutions in the digital era, commenced the trading o...

2025-06-03 06:00 3630

Denim Reimagined for Home, Mobilious Brings Jeans to Your Living Room

LOS ANGELES, June 2, 2025 /PRNewswire/ -- Mobilious today unveils three denim-upholstered sofas—Nuvola , Fiorello , and Bluoro —that translate ...

2025-06-03 01:47 2098

Recap of the "Shanghai Summer" Global Campaign – Osaka Edition

OSAKA, Japan, June 2, 2025 /PRNewswire/ -- On the afternoon of May 21, 2025, the "Shanghai Select – Made in Shanghai Showcase" and the Osaka edition of the "Shanghai Summer" global promotional campaign officially launched at Grand Green Osaka in Umeda, Japan. Mr. Fang Wei, Deputy Consul General o...

2025-06-02 23:53 2823

What are Akuvox's Latest Offerings that Cement its Leadership in Smart Intercoms?

XIAMEN, China, June 2, 2025 /PRNewswire/ -- Akuvox , a leader in smart intercom and smart home solutions, proudly announced the launch of two groundbreaking products:X937 Surveillance + Intercom AI Monitor and the X910 Single-B...

2025-06-02 22:00 2364

U.S. Marshal to Hold a Public Auction of 1,951,443 shares of Common Stock of Future FinTech Pursuant to the NY Court in Favor of FT Global Capital

MIAMI BEACH, Fla., June 2, 2025 /PRNewswire/ -- FT Global Capital, Inc. ("FT Global"), aMiami Beach-based registered broker-dealer and investment banking firm, announced today the most recent development in its effort to enforce its judgment against Future FinTech Group Inc. (Nasdaq: FTFT) ("Futu...

2025-06-02 21:30 1994

Maxim's de Paris expands to the US market with cutting-edge 'Seine X' home coffee machine

Bringing the Parisian café to American homes PARIS, June 2, 2025 /PRNewswire/ -- Maxim's de Paris has announced its entry into the competitive US home coffee market with the launch of 'Seine X' - the world's first intelligent semi-automatic three-in-one variable pressure espresso machine, a cate...

2025-06-02 21:00 2859

Health In Tech Chief Growth Officer to Be Featured on "New to The Street" Interview at NYSE

STUART, Fla., June 2, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is pleased to share that Chief Growth OfficerDustin Plantholt will be featured in an upcoming interview on "New to The Street," filmed live at the New York S...

2025-06-02 20:45 3342

Taoping Selected for New US$2.8 Million Agricultural Product Supply Contract; Company Continues to Build Momentum in Important Growth Market

SHENZHEN, China, June 2, 2025 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, today announced that it has been selected for a newRMB 20 million ( US$2.8 million) sales and purchase agreement. Under the latest agreeme...

2025-06-02 20:30 3302

OnCusp Therapeutics Announces Encouraging Initial Phase 1a Results from Ongoing First-in-Human Study Evaluating its CDH6-Directed Antibody-Drug Conjugate, CUSP06, in Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors at the 2025 ASCO Annual Meeting

CUSP06 is a CDH6-directed ADC with a differentiated profile and potentially best-in-class activity CUSP06 demonstrated a manageable safety profile, consistent with other TOP1-inhibitor ADCs Promising signs of efficacy were observed in patients with heavily pretreated platinum-resistant high-gra...

2025-06-02 19:32 1957

J INTS BIO to Present Global Clinical Results from JIN-A02, a Fourth-Generation EGFR-TKI, at ASCO 2025

Significant anti-tumor responses and reduction of brain metastases observed SEOUL, South Korea, June 1, 2025 /PRNewswire/ -- J INTS BIO, a company specializing in the development of therapeutics for cancer and rare diseases, officially announced interim results from the global Phase 1/2 clini...

2025-06-02 10:22 2461

Peacock 1953 Aircraft Hand Watch: Heritage Meets Horological Innovation in a Tribute to China's Watchmaking Pioneers

SHENZHEN, China, June 1, 2025 /PRNewswire/ -- Peacock  Watch today launches thePeacock Perfection Classic 1953 "Aircraft Hand" , a limited-e...

2025-06-02 08:19 2221

CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting

SHANGHAI, June 1, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of the pivotal Phase II clinical trial in China (CT041-ST-01, NCT04581473) investigating satricabtagene au...

2025-06-02 08:15 1899

2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer

SAN FRANCISCO, and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2025-06-02 08:00 3784